188 related articles for article (PubMed ID: 25263634)
21. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
Douglas JG; Arndt CA; Hawkins DS
Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885
[TBL] [Abstract][Full Text] [Related]
22. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy.
Ladra MM; Mandeville HC; Niemierko A; Padera TP; Friedmann AM; MacDonald SM; Ebb D; Chen YL; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):358-67. PubMed ID: 25864172
[TBL] [Abstract][Full Text] [Related]
23. Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical study.
Fuchs J; Dantonello TM; Blumenstock G; Kosztyla D; Klingebiel T; Leuschner I; Schuck A; Niggli FK; Koscielniak E; Seitz G
Ann Surg; 2014 Jun; 259(6):1166-72. PubMed ID: 24045440
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
[TBL] [Abstract][Full Text] [Related]
25. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
26. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
27. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?
Schuck A; Mattke AC; Schmidt B; Kunz DS; Harms D; Knietig R; Treuner J; Koscielniak E
J Clin Oncol; 2004 Jan; 22(1):143-9. PubMed ID: 14701776
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of early radiographic response in children and adolescents with embryonal rhabdomyosarcoma stage IV, metastases confined to the lungs: A report from the Cooperative Weichteilsarkom Studiengruppe (CWS).
Sparber-Sauer M; von Kalle T; Seitz G; Dantonello T; Scheer M; Münter M; Fuchs J; Ladenstein R; Bielack SS; Klingebiel T; Koscielniak E;
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28306214
[TBL] [Abstract][Full Text] [Related]
29. Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study.
Vogin G; Helfre S; Glorion C; Mosseri V; Mascard E; Oberlin O; Gaspar N
Eur J Cancer; 2013 Apr; 49(6):1314-23. PubMed ID: 23402991
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
31. Circulating T-regulatory cells in PNET: a prospective study.
Tilak TV; Sharawat S; Gupta R; Agarwala S; Vishnubhatla S; Bakhshi S
Pediatr Blood Cancer; 2014 Feb; 61(2):228-32. PubMed ID: 23997029
[TBL] [Abstract][Full Text] [Related]
32. Myogenin and desmin immunohistochemistry in the assessment of post-chemotherapy genitourinary embryonal rhabdomyosarcoma: prognostic and management implications.
Godbole P; Outram A; Wilcox DT; Duffy PG; Sebire NJ
J Urol; 2006 Oct; 176(4 Pt 2):1751-4. PubMed ID: 16945640
[TBL] [Abstract][Full Text] [Related]
33. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
34. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
35. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
36. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
[TBL] [Abstract][Full Text] [Related]
37. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
38. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
[TBL] [Abstract][Full Text] [Related]
39. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
